Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woolworths | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$37.28B | 343.3x | -3.72 | A$30.63 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.4% Upside | Upgrade to Pro+ | |
Coles Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$25.35B | 22.6x | 12.56 | A$18.99 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
Endeavour Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$7.54B | 18.6x | -4.57 | A$4.15 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Metcash | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$3.42B | 12.8x | -0.95 | A$3.11 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Jatcorp | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$45.80M | 20.2x | 0.13 | A$0.56 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aumake | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$15.04M | -1.3x | 0.26 | A$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |